同和药业 (300636.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(同和药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 559,661,869.75381,754,020.70220,746,478.69719,908,426.87528,274,967.87335,975,141.33179,771,415.86
 营业利润(元) 89,219,398.5561,133,476.4435,018,129.78106,332,395.6479,625,351.7545,211,270.1429,556,664.26
 利润总额(元) 89,160,134.2161,074,212.1034,958,865.44106,149,659.6479,592,615.7545,178,534.1429,523,928.26
 净利润(元) 78,653,167.8657,030,832.7133,096,474.74100,667,359.9774,486,244.4842,638,385.5526,828,215.64
 归属于母公司股东的净利润(元) 78,653,167.8657,030,832.7133,096,474.74100,667,359.9774,486,244.4842,638,385.5526,828,215.64
盈利能力:
 销售毛利率(%) 31.2933.3335.8932.4329.3128.1430.69
 销售净利率(%) 14.0514.9414.9913.9814.1012.6914.92
 净资产收益率(%) 4.564.762.85----
 总资产报酬率ROA(%) 3.232.741.77----
 投入资本回报率ROIC(%) 3.142.671.585.394.082.361.53
营运能力:
 存货周转率(次) 0.800.540.32----
 应收账款周转率(次) 5.534.652.19----
 总资产周转率(次) 0.210.170.10----
偿债能力:
 资产负债率(%) 30.3042.9241.6641.5840.8151.8151.08
 股东权益比率(%) 69.7057.0858.3458.4259.1948.1948.92
 已获利息倍数(倍) -21.0470.7912.6514.8135.9711.9534.03
 流动比率 1.690.971.241.321.391.361.63
 速动比率 0.920.270.390.430.470.440.54
发展能力:
 营业收入增长率(%) 5.9413.6322.7921.5823.4321.0630.89
 营业利润增长率(%) 12.0535.2218.4820.378.16-3.8033.92
 税后利润增长率(%) 5.5933.7523.3624.1011.930.2633.22
 净资产增长率(%) 74.5635.3741.5848.5943.7719.8514.91
 总资产增长率(%) 48.2414.2918.7318.4716.6328.3033.98

前瞻产业研究院